mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-07 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |